Similar results were obtained by Ichikawa and co-authors on colon tumors, where in mice lacking S100A9 the authors observed significantly reduced tumor incidence, growth and metastasis, decreased chemokine levels and declined infiltration of CD11b+ Gr1+ cells within tumors and premetastatic organs [91]. The gene discussed is S100A9; the disease is neoplasm.